Harvard Apparatus Regenerative Technology

About:

Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition

Website: https://hregen.com/

Twitter/X: BiostageInc

Top Investors: Connecticut Children’s Medical Center, Bin Zhao

Description:

Biostage is a biotechnology company developing esophageal implants for patients battling life-threatening conditions. It uses the patient’s stem cells grown on a porous plastic tubular scaffold to regenerate the esophagus after it has been removed by a surgeon due to cancer, trauma, or birth defects. Once the regeneration is complete, typically after about 3 months, the scaffold is removed via the mouth. It requires no surgical incision to remove the scaffold.

Total Funding Amount:

$37.1M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Holliston, Massachusetts, United States

Founded Date:

2012-05-03

Contact Email:

bioscience(AT)harvardapparatus.com

Founders:

David Green

Number of Employees:

11-50

Last Funding Date:

2024-08-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai